03.02.2011
Dualsystems Biotech announces 3 year project to investigate fibrodysplasia ossificans progressiva
Dualsystems Biotech announced today that it has obtained funding to carry out a 3 year project to investigate the molecular mechanisms underlying Fibrodysplasia ossificans progressive (FOP, Münchmeyer syndrome)...
Our satisfied customers say...
"The scientists at Dualsystems were helpful collaborators, very responsive to our requests, and screened additional libraries as needed to provide us with compelling data. The final results included several confirmed interacting proteins for our targets of interest and we were very satisfied with the yeast 2-hybrid service"